Richard Idro
ID: UNCST-2021-R013599
|
Dihydroartemisinin-piperaquine and azithromycin for the post-discharge management of children with severe anaemia in Malawi, Kenya and Uganda; A, multicentre, parallel-group, two-arm, randomised, double-blind superiority trial.
REFNo: HS2815ES
To determine if PDMC with four courses of monthly AZ treatment in combination with four months of weekly DP is superior to PDMC with weekly DP-alone in reducing non-malaria SCCV by six months post-discharge in children aged <5 years admitted with severe anaemia (Hb<5g/dl) who are ready to be discharged and are clinically stable and able to switch to oral medication,
|
Jinja, Jinja City
Kitgum, Municipality
|
Uganda |
2023-05-25 12:04:54 |
2026-05-25 |
958 |
Children aged less than 5 years, with severe anemia. |
Training and Research Unit of Excellence, Blantyre, Malawi |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
.jpg)
|
David Meya Bisagaya
ID: UNCST-2019-R000837
|
Platform Trial For Cryptococcal Meningitis - PLATFORM-CM
REFNo: HS2649ES
The purpose of this study is to know whether this oral form of amphotericin (MAT2203) is safe and effective in the treatment of people sick with cryptococcal meningitis.
|
Mbarara, Mbarara
Masaka, Masaka
Kampala, Kampala
|
Uganda |
2023-05-25 12:01:51 |
2026-05-25 |
270 |
Adult (18 years and above) males and females HIV-infected persons with cryptococcal meningitis. |
Matinas BioPharma Nanotechnologies, Inc. |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Dominik Biesalski
ID:
|
The Drivers, Effects and Measurement of Time Use Among the Urban Poor: Evidence from Uganda
REFNo: SS1674ES
Get insights into the time use patterns of urban workers and understand their effects on productivity and well-being.
|
Kampala, Kampala
|
Germany |
2023-05-11 14:41:00 |
2026-05-11 |
200 |
Workers who are older than 18 years old, both men and women of all tribes |
Private Enterprise Development in Low-Income Countries (PEDL) |
Social Science and Humanities |
Clinical Trial |
Degree Award |
|
James Davis KATUMBA
ID:
|
Uncontrolled asthma among adolescents in selected secondary schools in Kampala City: Prevalence, associated factors, in-school needs, pathways to care and effectiveness of an mHealth Self-management app
REFNo: HS2791ES
To determine the effectiveness, acceptability and feasibility of the KmAsthma self-management app in improving the control of asthma among day scholar secondary school adolescents 12-19 years old in Kampala City Uganda.,To examine pathways to asthma care and their influence on asthma control among secondary school adolescents with asthma in Kampala City Uganda ,To establish the in-school needs associated with asthma control among adolescents in selected secondary schools in Kampala City Uganda ,To determine the prevalence of and factors associated with uncontrolled asthma among adolescents in selected secondary schools in Kampala City Uganda ,To establish the prevalence of and factors associated with uncontrolled asthma, in-school needs, pathways to asthma care, and effectiveness of KmAsthma Self-management app intervention to control asthma among adolescents in selected secondary schools in Kampala City Uganda,
|
Kampala, Kawempe, Rubaga, Makindye, Kampala Central, Nakawa
|
Uganda |
2023-05-02 22:22:49 |
2026-05-02 |
323 |
Secondary school adolescents in Kampala City Uganda who will provide written informed consent (or assent plus consent from parents in case of minors) during the time of the study. |
Self Sponsored |
Medical and Health Sciences |
Clinical Trial |
Degree Award |
|
John Kellett Gale
ID:
|
Can continuous non-invasive monitoring of movement predict and detect clinical deterioration of hospital patients earlier and more efficiently than traditional intermittent observations?
REFNo: HS2765ES
To determine if continuously collected accelerometer data can indicate and identify clinical deterioration of acutely ill hospitalised patients before intermittently collected vital signs.
|
Masaka, Ssenyange
|
Ireland |
2023-05-02 22:11:25 |
2026-05-02 |
1100 |
All non-pregnant patients aged 18 years or over admitted to the medical ward for any medical condition who are competent to provide consent to participate in the study or have a surrogate decision maker who can consent on their behalf. Patients may decide to participate or withdraw from the study at any time during their hospitalization. |
Dr John Kellett |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|
